Patients with thyroid cancer will take a small dose of I after undergoing a total thyroidectomy. Single-photon emission computed tomography (SPECT) is used to diagnose whether thyroid tissue remains in the body. However, it is difficult for human eyes to observe the specificity of SPECT images in different categories, and it is difficult for doctors to accurately diagnose the residual thyroid tissue in patients based on SPECT images. At present, the research on the classification of thyroid tissue residues after thyroidectomy is still in a blank state. This paper proposes a ResNet-18 fine-tuning method based on the convolutional neural network model. First, preprocess the SPECT images to improve the image quality and remove background interference. Secondly, use the preprocessed image samples to fine-tune the pretrained ResNet-18 model to obtain better features and finally use the Softmax classifier to diagnose the residual thyroid tissue. The method has been tested on SPECT images of 446 patients collected by local hospital and compared with the widely used lightweight network SqueezeNet model and ShuffleNetV2 model. Due to the small data set, this paper conducted 10 random grouping experiments. Each experiment divided the data set into training set and test set at a ratio of 3:1. The accuracy and sensitivity rates of the model proposed in this paper are 96.69% and 94.75%, which are significantly higher than other models (p < 0.05). The specificity and precision rates are 99.6% and 99.96%, respectively, and there is no significant difference compared with other models. (p > 0.05). The area under the curve of the proposed model, SqueezeNet, and ShuffleNetv2 are 0.988 (95% CI, 0.941-1.000), 0.898 (95% CI, 0.819-0.951) (p = 0.0257), and 0.885 (95% CI, 0.803-0.941) (p = 0.0057) (p < 0.05). We prove that this thyroid tissue residue classification system can be used as a computer-aided diagnosis method to effectively improve the diagnostic accuracy of thyroid tissue residues. While more accurately diagnosing patients with residual thyroid tissue in the body, we try our best to avoid the occurrence of overtreatment, which reflects its potential clinical application value.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581297PMC
http://dx.doi.org/10.3389/fonc.2021.762643DOI Listing

Publication Analysis

Top Keywords

thyroid tissue
32
spect images
20
residual thyroid
16
thyroid
9
tissue
8
convolutional neural
8
neural network
8
diagnose residual
8
tissue residues
8
data set
8

Similar Publications

Thyroid tissue is sensitive to the effects of endocrine disrupting substances, and this represents a significant health concern. Histopathological analysis of tissue sections of the rat thyroid gland remains the gold standard for the evaluation for agrochemical effects on the thyroid. However, there is a high degree of variability in the appearance of the rat thyroid gland, and toxicologic pathologists often struggle to decide on and consistently apply a threshold for recording low-grade thyroid follicular hypertrophy.

View Article and Find Full Text PDF

Nr4a1 and Nr4a3 redundantly control clonal deletion and contribute to an anergy-like transcriptome in auto-reactive thymocytes to impose tolerance in mice.

Nat Commun

January 2025

Division of Rheumatology, Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Department of Medicine, University of California, San Francisco, CA, 94143, USA.

The Nr4a nuclear hormone receptors are transcriptionally upregulated in response to antigen recognition by the T cell receptor (TCR) in the thymus and are implicated in clonal deletion, but the mechanisms by which they operate are not clear. Moreover, their role in central tolerance is obscured by redundancy among the Nr4a family members and by their reported functions in Treg generation and maintenance. Here we take advantage of competitive bone marrow chimeras and the OT-II/RIPmOVA model to show that Nr4a1 and Nr4a3 are essential for the upregulation of Bcl2l11/BIM and thymic clonal deletion by self-antigen.

View Article and Find Full Text PDF

Introduction Thyroid malignancy remains a significant global health concern, making the accurate differentiation between benign and malignant thyroid nodules crucial for optimal patient management. Fine-needle aspiration cytology (FNAC) is the gold-standard preoperative diagnostic tool, and The Bethesda System for Reporting Thyroid Cytopathology provides a standardized framework for interpretation. This 10-year retrospective study evaluated the malignancy risk in surgically treated patients with thyroid nodules classified as Bethesda Category III by comparing FNAC findings with histopathological outcomes.

View Article and Find Full Text PDF

Purpose: Type 2 deiodinase (D2), encoded by DIO2 gene, catalyzes the activation of the prohormone thyroxine (T4) into the bioactive hormone triiodothyronine (T3) in peripheral tissues, thereby regulating the intracellular Thyroid Hormone (TH) availability. Recently, several studies have demonstrated that a drastic increase in the peripheral activation of TH, via D2, fosters tumor progression, metastasis, and immunity.

Methods: To further prove the clinical relevance of D2 in human cancer, based on public Database of The Cancer Genome Atlas (TCGA), we conducted a pan-cancer analysis of DIO2 expression in various cancer types and investigated the association of DIO2 expression with the tumor microenvironment (TME) components and immune cell infiltration, along with the DIO2 genetic alteration types.

View Article and Find Full Text PDF

Lampreys are early jawless vertebrates that are the key to understanding the evolution of vertebrates. However, the lack of cytomic studies on multiple lamprey organs has hindered progress in this field. Therefore, the present study constructed a comprehensive cell atlas comprising 604,460 cells/nuclei and 70 cell types from 14 lamprey tissue samples.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!